NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) between October 31, 2024, to April 30, 2025, both dates inclusive. You are hereby notified that the class action lawsuit Joseph Hauser v. Organon & Co., et al. (Case No. 2:25-cv-05322) has been commenced in the United States District Court for the District of New Jersey ...

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA) between August 8, 2024, to May 8, 2025, both dates inclusive. You are hereby notified that the class action lawsuit Karthik Trichur Sundaram v. Iovance Biotherapeutics, Inc., et al. (Case No. 3:25-cv-04177) has been commenced in the United States Dist ...

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP, a distinguished law firm with over 125 years of history, informs investors that a class action lawsuit has been filed Open Lending Corporation (Open Lending or the Company) (NASDAQ: LPRO) on behalf of a class consisting of all investors that purchased or otherwise acquired Open Lending securities between February 24, 2022 and March 31, 2025, both dates inclusive (the "Class Period"). Deadline to sign up: If you are an inve ...

Core Viewpoint - A class action lawsuit has been filed against Compass Group Diversified Holdings LLC due to alleged failures in financial reporting and internal controls, leading to significant stock price decline following the revelation of these issues [1][3][4]. Company Summary - The lawsuit, Nicholas Moreno v. Compass Group Diversified Holdings LLC, was initiated for investors who acquired securities between May 1, 2024, and May 7, 2025 [1]. - Allegations include the company's lack of effective internal controls over financial reporting and failure to disclose critical information regarding its subsidiary, Lugano Holding, Inc., which had undisclosed financing arrangements and irregularities in financial metrics [3]. - On May 7, 2025, Compass announced that its fiscal 2024 financial statements could no longer be relied upon due to an internal investigation into Lugano, leading to the resignation of Lugano's CEO without severance [4]. Market Impact - Following the announcement of the investigation, Compass' stock price plummeted from $17.25 per share on May 7, 2025, to $6.55 per share on May 8, 2025, indicating a dramatic loss in market value [5].

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP, a distinguished law firm with over 125 years of history, informs investors that a class action lawsuit has been filed against Civitas Resources, Inc. ("Civitas " or the "Company") (NYSE: CIVI) on behalf of a class consisting of all investors that purchased or otherwise acquired Civitas securities between February 27, 2024 and February 24, 2025, both dates inclusive (the "Class Period"). Deadline to sign up: If you are an i ...

NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Humana Inc. (“Humana” or the “Company”) (NYSE:HUM). The investigation concerns whether Humana and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] On May 1, 2025, the U.S. Department of Justice filed a complaint against insurance broker organizations, including Humana, alleging t ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Fluence Energy, Inc. due to significant losses suffered by investors, particularly following a substantial decline in the company's stock value and allegations of misleading statements regarding its financial health and business relationships [2][4][5]. Group 1: Company Overview - Fluence Energy, Inc. is publicly traded on NASDAQ under the ticker FLNC [2]. - The company has faced a 49% year-over-year revenue decline as reported on February 11, 2025, leading to a stock price drop of over 45% [5]. Group 2: Legal Allegations - The complaint against Fluence alleges violations of federal securities laws, including making false or misleading statements and failing to disclose critical information about its relationships with major partners Siemens AG and The AES Corporation [4]. - Specific allegations include claims that Siemens Energy accused Fluence of engineering failures and fraud, and that Fluence's financial results were inflated as these partners were moving to divest [4]. Group 3: Investor Impact - Investors who suffered losses exceeding $75,000 between October 28, 2021, and February 10, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal options [1][2]. - The deadline for investors to seek the role of lead plaintiff in the federal securities class action is May 12, 2025 [2][6].

Core Viewpoint - A class action lawsuit has been initiated against Skyworks Solutions, Inc. due to allegations of misleading investors regarding the company's expected revenue and business prospects during a specified period [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit spans from August 8, 2023, to February 5, 2025, during which investors are claimed to have been provided with material information about Skyworks' expected revenue for fiscal year 2025 [2]. - The lawsuit alleges that the defendants expressed confidence in Skyworks' ability to grow its mobile business and diversify its offerings through new technology investments [2]. Group 2: Financial Performance - On February 5, 2025, Skyworks reported its financial results for Q1 of fiscal year 2025 and issued lower-than-expected revenue guidance for Q2, attributing this to an intensified competitive landscape [3]. - Following the announcement, Skyworks' stock price plummeted from $87.08 per share to $65.60 per share on February 6, 2025, marking a decline of over 24% in just one day [3]. Group 3: Legal Process - Investors who suffered losses in Skyworks securities have until May 5, 2025, to request appointment as lead plaintiff in the lawsuit, although participation in any recovery does not require serving as lead plaintiff [4]. Group 4: Law Firm Background - Levi & Korsinsky, the law firm handling the case, has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Zynex, Inc. due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by May 19, 2025 [2][4]. Group 1: Allegations Against Zynex - The complaint alleges that Zynex and its executives made false or misleading statements and failed to disclose critical information, including shipping excess products, inflating revenue, and facing scrutiny from insurers like Tricare [4]. - A report published by medical journal STAT accused Zynex of an "oversupplying scheme," leading to insurers removing the company from their networks [5]. - Following the report, Zynex's stock price dropped by $0.50 per share, or 5%, closing at $9.35 on June 4, 2024, amid heavy trading volume [5]. Group 2: Financial Performance and Market Reaction - On March 11, 2025, Zynex reported a significant revenue shortfall for Q4 2024, attributing it to slower payments from certain payers and a temporary suspension of payments from Tricare [6]. - The announcement led to a drastic decline in Zynex's stock price, which fell by $3.59 per share, or 51.3%, closing at $3.41 on March 12, 2025, also on unusually heavy trading volume [7].